About
Basic Data Updated:
22 days agoAurobindo Pharma Ltd is known as a vertically-integrated pharmaceutical formulations manufacturer, according to its credit rating report. The company boasts 14 formulation manufacturing facilities, with three located in the US, one in Brazil, and one in Portugal. Additionally, it has 11 active pharmaceutical ingredients manufacturing facilities. These facilities have received regulatory approvals from major international agencies. APL was established in 1986 and its registered office is situated in Telangana.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L24239TG1986PLC015190 |
| Company No. | 015190 |
| Stock Symbol | BSE : 524804 NSE : AUROPHARMA |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 26 Dec 1986 |
| Date of AGM | 25 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Hyderabad |
Financials of Aurobindo Pharma Ltd
Aurobindo Pharma Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 10.6% increase. The company also saw a substantial fall in profitability, with a 15.42% decrease in profit. The company's net worth moved up by a moderate rise of 4.66%.
Corporate Structure
Unlock access to Aurobindo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Aurobindo Pharma Ltd
Unlock and access historical data on people associated with Aurobindo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
MR
Mr Reddy
Company SecretaryStatus: Current
MS
Mr Ssubramanian CFOStatus: Current
NK
Nityananda Kambam Managing DirectorAppointment Date: 30-Dec-1992
Status: Current
Board Members(9)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Export-Import Bank Of India Creation Date: 23 Dec 1999 | ₹15.00 Cr | Open |
State Bank Of India Creation Date: 05 Jun 1997 | ₹2,000.00 Cr | Open |
Dbs Bank Ltd Creation Date: 08 Jan 2013 | ₹164.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurobindo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Eugia Pharma Specialities Limited
Active
11 years 24 days Ragunathan Kannan and Madan Mettu are mutual person
Recent activity within the organization
Director Appointment
Deepali Pant Rajeev Joshi was appointed as a Director was appointed as a Director on 04 Mar 2024 & has been associated with this company since 2 months 8 days .
04 Mar 2024Annual General Meeting
Aurobindo Pharma Ltd last Annual general meeting of members was held on 25 Aug 2023 as per latest MCA records.
25 Aug 2023Balance Sheet
Aurobindo Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Santanu Mukherjee was appointed as a Director was appointed as a Director on 21 Mar 2023 & has been associated with this company since 1 year 1 month .
21 Mar 2023Charges
A charge with State Bank Of India of Rs. 2,000.00 cr registered on 05 Jun 1997 with Charge ID 80013576 was modified on 22 Feb 2023.
22 Feb 2023
Recent News, Updates & Announcement
- Aurobindo Pharma Q1 profit up 10 pc at Rs 571 cr.
With the product pipeline continuing to advance and execution of growth drivers proceeding as planned the company is confident that its fundamental strengths position it to create an upward trajectory ViceChairman and Managing Director K Nithyananda Reddy said.
Economic Times 13 Aug 2023
- Aurobindo Pharma Q1 Results Net profit drops 22 to 540 crore revenue up 10 YoY Mint.
Aurobindo Pharma Q1 Results The pharma majors revenue from operations during the first quarter of current fiscal stood at 68505 crore registering a rise of 99 per cent compared to 6236 crore in the yearago period.
mint 13 Aug 2023
- Aurobindo Pharma surges as arm gets nod to manufacture market Vancomycin Hydrochloride for injection.
Udaipur Kiran 07 Aug 2023
- Aurobindo Pharma arm in Puerto Rico to halt production for expansion works.
The Hindu 29 Jun 2023
Frequently asked questions
What is the Incorporation or founding date of Aurobindo Pharma Ltd?
